Skip to main navigation Skip to search Skip to main content

Tolicizumab effectively controls giant cell arteritis and prevents recurrence of steroid-induced concomitant toxoplasmosis chorioretinitis

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article numbere263369
JournalBMJ Case Reports
Volume18
Issue number2
DOIs
StatePublished - Feb 26 2025

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Autoimmunity
  • Macula
  • Retina
  • Vasculitis
  • Recurrence
  • Toxoplasmosis, Ocular/drug therapy
  • Humans
  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Giant Cell Arteritis/drug therapy
  • Treatment Outcome
  • Prednisone/adverse effects
  • Glucocorticoids/adverse effects
  • Female
  • Aged
  • Chorioretinitis/chemically induced

Cite this